nodes	percent_of_prediction	percent_of_DWPC	metapath
Mequitazine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.0813	0.0947	CbGpPWpGaD
Mequitazine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0221	0.0258	CbGpPWpGaD
Mequitazine—CHRM2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0218	0.0254	CbGpPWpGaD
Mequitazine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0217	0.0253	CbGpPWpGaD
Mequitazine—CHRM2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0213	0.0248	CbGpPWpGaD
Mequitazine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0186	0.0217	CbGpPWpGaD
Mequitazine—CHRM2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0183	0.0213	CbGpPWpGaD
Mequitazine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0182	0.0212	CbGpPWpGaD
Mequitazine—CHRM2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0179	0.0209	CbGpPWpGaD
Mequitazine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0131	0.0153	CbGpPWpGaD
Mequitazine—CHRM2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0129	0.0151	CbGpPWpGaD
Mequitazine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0126	0.0147	CbGpPWpGaD
Mequitazine—CHRM2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0124	0.0145	CbGpPWpGaD
Mequitazine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0122	0.0142	CbGpPWpGaD
Mequitazine—CHRM2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.012	0.014	CbGpPWpGaD
Mequitazine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0118	0.0138	CbGpPWpGaD
Mequitazine—CHRM2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0116	0.0136	CbGpPWpGaD
Mequitazine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0116	0.0135	CbGpPWpGaD
Mequitazine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0115	0.0134	CbGpPWpGaD
Mequitazine—CHRM2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0114	0.0133	CbGpPWpGaD
Mequitazine—CHRM2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0113	0.0132	CbGpPWpGaD
Mequitazine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.011	0.0129	CbGpPWpGaD
Mequitazine—CHRM2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0109	0.0127	CbGpPWpGaD
Mequitazine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0107	0.0125	CbGpPWpGaD
Mequitazine—CHRM2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0105	0.0123	CbGpPWpGaD
Mequitazine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0103	0.012	CbGpPWpGaD
Mequitazine—CHRM2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0101	0.0118	CbGpPWpGaD
Mequitazine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00995	0.0116	CbGpPWpGaD
Mequitazine—CHRM2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00979	0.0114	CbGpPWpGaD
Mequitazine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00978	0.0114	CbGpPWpGaD
Mequitazine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00966	0.0112	CbGpPWpGaD
Mequitazine—CHRM2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00962	0.0112	CbGpPWpGaD
Mequitazine—CHRM2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0095	0.0111	CbGpPWpGaD
Mequitazine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.009	0.0105	CbGpPWpGaD
Mequitazine—CHRM2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00885	0.0103	CbGpPWpGaD
Mequitazine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00749	0.00873	CbGpPWpGaD
Mequitazine—CHRM2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00737	0.00859	CbGpPWpGaD
Mequitazine—CHRM2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00675	0.00786	CbGpPWpGaD
Mequitazine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0063	0.00733	CbGpPWpGaD
Mequitazine—CHRM2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0062	0.00722	CbGpPWpGaD
Mequitazine—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00606	0.00705	CbGpPWpGaD
Mequitazine—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00584	0.0068	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00517	0.00602	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00502	0.00585	CbGpPWpGaD
Mequitazine—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00453	0.00527	CbGpPWpGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00434	0.00505	CbGpPWpGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00427	0.00497	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0042	0.00489	CbGpPWpGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00419	0.00487	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00416	0.00484	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00412	0.0048	CbGpPWpGaD
Mequitazine—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00412	0.00479	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00409	0.00476	CbGpPWpGaD
Mequitazine—Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.00402	0.0285	CrCbGaD
Mequitazine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.00391	0.0277	CrCbGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00373	0.00434	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00366	0.00426	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0036	0.00419	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00359	0.00418	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00353	0.00411	CbGpPWpGaD
Mequitazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.00351	0.0249	CrCbGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00347	0.00404	CbGpPWpGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00347	0.00404	CbGpPWpGaD
Mequitazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.00346	0.0245	CrCbGaD
Mequitazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.00331	0.0234	CrCbGaD
Mequitazine—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.0033	0.0234	CrCbGaD
Mequitazine—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00328	0.00381	CbGpPWpGaD
Mequitazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.00321	0.0228	CrCbGaD
Mequitazine—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.00312	0.0221	CrCbGaD
Mequitazine—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00308	0.00358	CbGpPWpGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0029	0.00338	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00286	0.00332	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00279	0.00325	CbGpPWpGaD
Mequitazine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.00276	0.0196	CrCbGaD
Mequitazine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00274	0.0032	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00274	0.00319	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00273	0.00318	CbGpPWpGaD
Mequitazine—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00269	0.00313	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00269	0.00313	CbGpPWpGaD
Mequitazine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00268	0.00312	CbGpPWpGaD
Mequitazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.00267	0.019	CrCbGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00261	0.00304	CbGpPWpGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00254	0.00295	CbGpPWpGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00252	0.00293	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0025	0.00291	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00249	0.00289	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00245	0.00285	CbGpPWpGaD
Mequitazine—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00242	0.00282	CbGpPWpGaD
Mequitazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.0024	0.017	CrCbGaD
Mequitazine—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00238	0.00277	CbGpPWpGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00236	0.00274	CbGpPWpGaD
Mequitazine—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00235	0.00274	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00235	0.00273	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00232	0.0027	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00231	0.00269	CbGpPWpGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00228	0.00266	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00225	0.00262	CbGpPWpGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00224	0.00261	CbGpPWpGaD
Mequitazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.00222	0.0157	CrCbGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00222	0.00258	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00221	0.00257	CbGpPWpGaD
Mequitazine—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00219	0.00255	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00218	0.00254	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00217	0.00253	CbGpPWpGaD
Mequitazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.00217	0.0154	CrCbGaD
Mequitazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.00215	0.0152	CrCbGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00214	0.00249	CbGpPWpGaD
Mequitazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.00214	0.0151	CrCbGaD
Mequitazine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00213	0.00248	CbGpPWpGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00213	0.00248	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0021	0.00244	CbGpPWpGaD
Mequitazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.0021	0.0149	CrCbGaD
Mequitazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.00208	0.0147	CrCbGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00207	0.0024	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00203	0.00237	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00202	0.00235	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00199	0.00231	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00196	0.00228	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00193	0.00224	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00192	0.00224	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0019	0.00221	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00189	0.0022	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00189	0.0022	CbGpPWpGaD
Mequitazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.00188	0.0134	CrCbGaD
Mequitazine—Mianserin—DRD3—attention deficit hyperactivity disorder	0.00188	0.0133	CrCbGaD
Mequitazine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	0.00188	0.0133	CrCbGaD
Mequitazine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00187	0.00218	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00187	0.00218	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00186	0.00217	CbGpPWpGaD
Mequitazine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	0.00185	0.0131	CrCbGaD
Mequitazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00179	0.00209	CbGpPWpGaD
Mequitazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.00179	0.0127	CrCbGaD
Mequitazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	0.00178	0.0126	CrCbGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00177	0.00206	CbGpPWpGaD
Mequitazine—Mianserin—SLC6A3—attention deficit hyperactivity disorder	0.00175	0.0124	CrCbGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00174	0.00203	CbGpPWpGaD
Mequitazine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	0.00171	0.0122	CrCbGaD
Mequitazine—Mianserin—ADRA2A—attention deficit hyperactivity disorder	0.00171	0.0122	CrCbGaD
Mequitazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.00169	0.012	CrCbGaD
Mequitazine—Quetiapine—DRD4—attention deficit hyperactivity disorder	0.00169	0.012	CrCbGaD
Mequitazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00167	0.00195	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00165	0.00193	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00163	0.0019	CbGpPWpGaD
Mequitazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	0.00159	0.0113	CrCbGaD
Mequitazine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00158	0.00183	CbGpPWpGaD
Mequitazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	0.00157	0.0111	CrCbGaD
Mequitazine—Promazine—DRD4—attention deficit hyperactivity disorder	0.00155	0.011	CrCbGaD
Mequitazine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00155	0.0018	CbGpPWpGaD
Mequitazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	0.00155	0.011	CrCbGaD
Mequitazine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00154	0.0018	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00154	0.00179	CbGpPWpGaD
Mequitazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	0.00153	0.0109	CrCbGaD
Mequitazine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00152	0.00177	CbGpPWpGaD
Mequitazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	0.00152	0.0108	CrCbGaD
Mequitazine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00151	0.00176	CbGpPWpGaD
Mequitazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	0.00151	0.0107	CrCbGaD
Mequitazine—Quetiapine—HTR1B—attention deficit hyperactivity disorder	0.0015	0.0106	CrCbGaD
Mequitazine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00149	0.00173	CbGpPWpGaD
Mequitazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	0.00149	0.0105	CrCbGaD
Mequitazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	0.00148	0.0105	CrCbGaD
Mequitazine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.00147	0.0104	CrCbGaD
Mequitazine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00147	0.00171	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00147	0.00171	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00146	0.0017	CbGpPWpGaD
Mequitazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	0.00146	0.0103	CrCbGaD
Mequitazine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00146	0.0017	CbGpPWpGaD
Mequitazine—Quetiapine—DRD3—attention deficit hyperactivity disorder	0.00146	0.0103	CrCbGaD
Mequitazine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00145	0.00169	CbGpPWpGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00145	0.00168	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00145	0.00168	CbGpPWpGaD
Mequitazine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.00144	0.0102	CrCbGaD
Mequitazine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00144	0.00168	CbGpPWpGaD
Mequitazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.00144	0.0102	CrCbGaD
Mequitazine—Quetiapine—DRD1—attention deficit hyperactivity disorder	0.00143	0.0101	CrCbGaD
Mequitazine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00143	0.00167	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00142	0.00166	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00142	0.00166	CbGpPWpGaD
Mequitazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	0.00141	0.01	CrCbGaD
Mequitazine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00141	0.00164	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0014	0.00163	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00138	0.00161	CbGpPWpGaD
Mequitazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	0.00137	0.0097	CrCbGaD
Mequitazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	0.00136	0.00962	CrCbGaD
Mequitazine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00135	0.00157	CbGpPWpGaD
Mequitazine—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	0.00133	0.00943	CrCbGaD
Mequitazine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00133	0.00154	CbGpPWpGaD
Mequitazine—Promazine—DRD1—attention deficit hyperactivity disorder	0.00132	0.00933	CrCbGaD
Mequitazine—Mianserin—SLC6A4—attention deficit hyperactivity disorder	0.00131	0.00928	CrCbGaD
Mequitazine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	0.0013	0.00923	CrCbGaD
Mequitazine—Mianserin—DRD2—attention deficit hyperactivity disorder	0.0013	0.00923	CrCbGaD
Mequitazine—Desipramine—SLC6A3—attention deficit hyperactivity disorder	0.00129	0.00913	CrCbGaD
Mequitazine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00126	0.00147	CbGpPWpGaD
Mequitazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	0.00125	0.00888	CrCbGaD
Mequitazine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00124	0.00144	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00124	0.00144	CbGpPWpGaD
Mequitazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.00122	0.00867	CrCbGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00122	0.00142	CbGpPWpGaD
Mequitazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	0.00121	0.00858	CrCbGaD
Mequitazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	0.00118	0.00839	CrCbGaD
Mequitazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	0.00118	0.00836	CrCbGaD
Mequitazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	0.00116	0.00825	CrCbGaD
Mequitazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	0.00116	0.00821	CrCbGaD
Mequitazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	0.00115	0.00814	CrCbGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00113	0.00131	CbGpPWpGaD
Mequitazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	0.00112	0.00795	CrCbGaD
Mequitazine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	0.0011	0.00781	CrCbGaD
Mequitazine—Trimipramine—DRD2—attention deficit hyperactivity disorder	0.00109	0.00776	CrCbGaD
Mequitazine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	0.00109	0.00774	CrCbGaD
Mequitazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	0.00108	0.00763	CrCbGaD
Mequitazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	0.00107	0.00759	CrCbGaD
Mequitazine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00107	0.00125	CbGpPWpGaD
Mequitazine—Promethazine—DRD2—attention deficit hyperactivity disorder	0.00105	0.00748	CrCbGaD
Mequitazine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00105	0.00123	CbGpPWpGaD
Mequitazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	0.00104	0.00738	CrCbGaD
Mequitazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	0.00103	0.0073	CrCbGaD
Mequitazine—Quetiapine—DRD2—attention deficit hyperactivity disorder	0.00101	0.00715	CrCbGaD
Mequitazine—Mianserin—HTR2A—attention deficit hyperactivity disorder	0.00101	0.00713	CrCbGaD
Mequitazine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	0.00101	0.00713	CrCbGaD
Mequitazine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000984	0.00115	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000971	0.00113	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000968	0.00113	CbGpPWpGaD
Mequitazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	0.000967	0.00686	CrCbGaD
Mequitazine—Desipramine—SLC6A4—attention deficit hyperactivity disorder	0.000963	0.00683	CrCbGaD
Mequitazine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00096	0.00112	CbGpPWpGaD
Mequitazine—Desipramine—DRD2—attention deficit hyperactivity disorder	0.000957	0.00679	CrCbGaD
Mequitazine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000956	0.00111	CbGpPWpGaD
Mequitazine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000953	0.00111	CbGpPWpGaD
Mequitazine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000947	0.0011	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000944	0.0011	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000935	0.00109	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000929	0.00108	CbGpPWpGaD
Mequitazine—Promazine—DRD2—attention deficit hyperactivity disorder	0.000927	0.00658	CrCbGaD
Mequitazine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00092	0.00107	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000869	0.00101	CbGpPWpGaD
Mequitazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	0.000866	0.00614	CrCbGaD
Mequitazine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000855	0.000996	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000849	0.000989	CbGpPWpGaD
Mequitazine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	0.000846	0.006	CrCbGaD
Mequitazine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000845	0.000984	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000842	0.00098	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000836	0.000973	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000832	0.000968	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000828	0.000964	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000828	0.000964	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000828	0.000963	CbGpPWpGaD
Mequitazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	0.000827	0.00586	CrCbGaD
Mequitazine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000817	0.000952	CbGpPWpGaD
Mequitazine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	0.000816	0.00579	CrCbGaD
Mequitazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	0.000816	0.00579	CrCbGaD
Mequitazine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000815	0.000948	CbGpPWpGaD
Mequitazine—Promethazine—HTR2A—attention deficit hyperactivity disorder	0.000815	0.00578	CrCbGaD
Mequitazine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000814	0.000948	CbGpPWpGaD
Mequitazine—Imipramine—DRD2—attention deficit hyperactivity disorder	0.000812	0.00576	CrCbGaD
Mequitazine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000812	0.000945	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000804	0.000936	CbGpPWpGaD
Mequitazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	0.000804	0.0057	CrCbGaD
Mequitazine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000799	0.00093	CbGpPWpGaD
Mequitazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	0.000795	0.00564	CrCbGaD
Mequitazine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000789	0.000919	CbGpPWpGaD
Mequitazine—Quetiapine—HTR2A—attention deficit hyperactivity disorder	0.00078	0.00553	CrCbGaD
Mequitazine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000777	0.000904	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000765	0.00089	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000761	0.000886	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000752	0.000876	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000752	0.000875	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000749	0.000872	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000742	0.000864	CbGpPWpGaD
Mequitazine—Desipramine—HTR2A—attention deficit hyperactivity disorder	0.00074	0.00525	CrCbGaD
Mequitazine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000739	0.000861	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00073	0.00085	CbGpPWpGaD
Mequitazine—Promazine—HTR2A—attention deficit hyperactivity disorder	0.000717	0.00508	CrCbGaD
Mequitazine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000691	0.000805	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00068	0.000792	CbGpPWpGaD
Mequitazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	0.000631	0.00447	CrCbGaD
Mequitazine—Imipramine—HTR2A—attention deficit hyperactivity disorder	0.000627	0.00445	CrCbGaD
Mequitazine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0006	0.000699	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000574	0.000668	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000565	0.000657	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000533	0.000621	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000525	0.000611	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000502	0.000584	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000494	0.000575	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000484	0.000564	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000477	0.000555	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000466	0.000543	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000459	0.000534	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000452	0.000526	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000444	0.000517	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000444	0.000517	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000438	0.00051	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000437	0.000509	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000431	0.000502	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000414	0.000483	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000414	0.000483	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000408	0.000476	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000408	0.000475	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000402	0.000468	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000393	0.000457	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000379	0.000441	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000331	0.000386	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000315	0.000367	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000286	0.000333	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000281	0.000328	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000271	0.000315	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000271	0.000315	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000267	0.00031	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000251	0.000292	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000249	0.00029	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000248	0.000289	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000217	0.000252	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000206	0.00024	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000164	0.000191	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000163	0.00019	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000152	0.000176	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000149	0.000174	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000108	0.000125	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	7.04e-05	8.2e-05	CbGpPWpGaD
